- Archives
-
-
-
-
-
-
-
-
-
-
-
-
Strategies for success
Stephen P. Mayock and Anita Koltay
Regulatory drivers for testing to better predict attributes
Andrew Parker, Ph.D.
Building a potent compound matrix to communicate with CMOs
Jim Lieberman, CIH
Michael Kowolenko of Wyeth talks about the convergence of vaccines and biotech
Gil Roth
What are the best practices for you?
Patrick Kager
Mastering the art of moving to a CMO
Mike Power
Are you ready?
John Daniels
Applying QbD concepts can help CMOs create value
Russ Somma, Ph.D. and Andrew A. Signore, PE, PMP-DBIA, CPIP
Where companies go wrong and how they can go right
Chris Driscoll
Build criteria for the best outsourcing experience
Sarah Crossman and Jeanne Lawson
Choosing a supplier that will satisfy your expectations
Mike Parry
The economics of choosing a CMO are changing
Burkhard Wichert, M.D., Mike Borlet and Raul Soikes
Project management and FDA interaction when an NDA is Fast Tracked
Gary A. Baker and Vince Ammoscato
The changing safety landscape in the EU and U.S.
Peter Summerfield and David Shoemaker
Guidelines for new supply chains
Chris Merchant and Lynn Rideout
Gil Roth
Steve Snyder
Gil Y. Roth
Risk and reward
Kristin Brooks
Moving from transactional to strategic partnership-based outsourcing
Kenneth Getz and Rachael Zuckerman
Making the leap from commercial to clinical
RS Kumar
A lean approach to compliance
John Avellanet
Market demand broadens bundled services
Kristin Brooks
IVRS becomes a valuable tool
Edward Montoya
Covance, Inc.
Gil Roth
Optimism is high among bio-contract manufacturers
William Downey
Technology is transforming manufacturing options
Donald F. Gerson
The outlook is bright for CMOs
Eric S. Langer
CMOs work to contain high potency biologics and APIs
Cindy Dubin
Part 2 of 2 on what to do when the FDA sends you a letter
Shamik Pandit
Biogen Idec blazes a path to California compliance
Stephen Barlas
Criteria for thriving in the new era
Michael W. Cislo
Contract Services Providers are finding homes in Indiana and other midwestern states
David L. Johnson
Cutting-edge systems strengthen the pharma production supply chain
Simon Kaye
Joint Development Agreements can protect outsourced IP
John Avellanet
Part 1 of 2 on what to do when the FDA sends you a letter
Shamik Pandit
AstraZeneca continues to send mixed messages about its long-term API sourcing strategy
Joanna Cosgrove
Time, quality and budget form the decision matrix
Selma Djukic
What lies ahead of the curve?
Brad Anderson
Are strategic outsourcing plans in development?
Hussain Mooraj and Fenella Sirkisoon
Are CDMOs the Next Big Thing?
Tom Spurgeon
Essential things to know
Steven Richter
Reviewing 2007's transactions and the trends they portend
Michael Martorelli
Maximizing the Strategic Value of Global R&D Outsourcing
Partha Ghosh and Kimberlee Luce
The Parenteral Drug Association plays a critical role
Kevin O\'Donnell
Wyeth's vaccine R&D head talks about vaccines past and future
Gil Y. Roth
Does WuXi's acquisition of AppTec signal contract manufacturing's return to the US?
Joanna Cosgrove
|
Magazine
